Table 1.
Comparison of Patients with and without Sarcopenia
| Sarcopenia |
Total | P-value | |||
|---|---|---|---|---|---|
| None | Sarcopenia | ||||
| Age years (M±SD) | 58.43 ±7.73 | 61.18 ±8.32 | 59.61 ±8.09 | 0.006 | |
| BMI k/m2 (M±SD) | 25.17 ±2.4 | 23.20 ±2.06 | 24.32 ±2.46 | 0.001 | |
| BCLC N (%) | BCLC A | 56 (37.6) | 18 (15.9) | 74 (28.2) | 0.001 |
| BCLC B | 79 (53) | 63 (55.8) | 142 (54.2) | ||
| BCLC C | 14 (9.4) | 32 (28.3) | 46 (17.6) | ||
| Etiology N (%) | Viral negative | 3 (2) | 3 (2.7) | 6 (2.3) | 0.909 |
| HBV | 9 (6) | 8 (7.1) | 17 (6.5) | ||
| HCV | 133 (89.3) | 100 (88.5) | 233 (88.9) | ||
| NASH | 3 (2) | 2 (1.8) | 5 (1.9) | ||
| Others | 1 (0.7) | 0 (0) | 1 (0.4) | ||
| Sex N (%) | Female | 53 (35.6) | 27 (23.9) | 80 (30.5) | 0.042 |
| Male | 96 (64.4) | 86 (76.1) | 182 (69.5) | ||
| Smoking N (%) | Nonsmoker | 123 (82.6) | 77 (68.1) | 200 (76.3) | 0.024 |
| Smoker | 11 (7.4) | 14 (12.4) | 25 (9.5) | ||
| Exsmoker | 15 (10.1) | 22 (19.5) | 37 (14.1) | ||
| Child-Pugh N (%) | A | 96 (64.4) | 50 (44.2) | 146 (55.7) | 0.001 |
| B | 53 (35.6) | 63 (55.8) | 116 (44.3) | ||
| Sarcopenia baseline N (%) | Grade 0 | 120 (80.5) | 53 (46.9) | 173 (66) | 0.001 |
| Grade 2 | 27 (18.1) | 44 (38.9) | 71 (27.1) | ||
| Grade 3 | 2 (1.3) | 16 (14.2) | 18 (6.9) | ||
| Sarcopenia 3th month N (%) | Grade 0 | 10 (6.7) | 4 (3.5) | 14 (5.3) | 0.001 |
| Grade 1 | 102 (68.5) | 48 (42.5) | 150 (57.3) | ||
| Grade 2 | 33 (22.1) | 52 (46) | 85 (32.4) | ||
| Grade 3 | 4 (2.7) | 9 (8) | 13 (5) | ||
| Sarcopenia 6th month N (%) | Grade 0 | 9 (6.1) | 3 (2.9) | 12 (4.8) | 0.006 |
| Grade 1 | 97 (66) | 51 (49.5) | 148 (59.2) | ||
| Grade 2 | 38 (25.9) | 41 (39.8) | 79 (31.6) | ||
| Grade 3 | 3 (2) | 8 (7.8) | 11 (4.4) | ||
| Sarcopenia 12th month N (%) | Grade 0 | 9 (6.6) | 0 (0) | 9 (4.8) | 0.006 |
| Grade 1 | 94 (69.1) | 28 (52.8) | 122 (64.6) | ||
| Grade 2 | 31 (22.8) | 22 (41.5) | 53 (28) | ||
| Grade 3 | 2 (1.5) | 3 (5.7) | 5 (2.6) | ||